Autor/a:
|
Berner-Rodoreda, Astrid; Rehfuess, Eva Annette; Klipstein-Grobusch, Kerstin; Cobelens, Frank; Raviglione, Mario; Flahaut, Antoine; Casamitjana, Núria; Fröschl, Günter; Skordis-Worral, Jolene; Abubakar, Ibrahim; Ashrafian, Hutan; Agardh, Anette; Visser, Leo; Schultsz, Constance; Plasència, Antoni; Jahn, Albrecht; Norton, Robyn; van Leeuwen, Remko; Hagander, Lars; Bärnighausen, Till
|
Abstract:
|
Global Health has not featured as prominently in the
European Union (EU) research agenda in recent years as it did in
the first decade of the new millennium, and participation of
low-income and middle-income countries (LMICs) in EU health
research has declined substantially. The Horizon Europe Research
and Innovation Framework adopted by the European Parliament in
April 2019 for the period 2021-2027 will serve as an important
funding instrument for health research, yet the proposed health
research budget to be finalised towards the end of 2019 was
reduced from 10% in the current framework, Horizon 2020, to 8%
in Horizon Europe. Our analysis takes the evolvement of Horizon
Europe from the initial framework of June 2018 to the framework
agreed on in April 2019 into account. It shows that despite some
improvements in terms of Global Health and reference to the
Sustainable Development Goals, European industrial
competitiveness continues to play a paramount role, with Global
Health research needs and relevant health research for LMICs
being only partially addressed. We argue that the globally
interconnected nature of health and the transdisciplinary nature
of health research need to be fully taken into account and acted
on in the new European Research and Innovation Framework. A
facilitated global research collaboration through Horizon Europe
could ensure that Global Health innovations and solutions
benefit all parts of the world including EU countries. |